I can't remember my exact comments on the last post which was blocked because of the heading used but the gist of it is that I have contacted another biostock analyst in the US who wrote an article some months ago titled "WHO WILL BE THE NEXT DENDREON?"
I responded back then by suggesting that Prima Biomed filled the required criteria and explained point by point as to whyI thought this.
The news I gave this analyst called David Miller from Biotech Stock Research this time was 2 fold: Listing on the NASDAQ internt by PRR plus a copy of the article yesterday on the "Litle Australian Biotech company being the next Dendreon".
So he well and truly now knows about the company and maybe he'll follow it more closely now given the US investors will soon be able buy shares in it. He was very supportive of Dendreon even in the times when others were sceptical about its potential.
cheers
Birdseye
another us biostock anayst knows potential
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.5¢ |
Change
0.060(20.3%) |
Mkt cap ! $515.6M | |||
| Open | High | Low | Value | Volume |
| 36.0¢ | 37.5¢ | 33.5¢ | $6.427M | 18.03M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 35.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.0¢ | 133736 | 5 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |